Feldene is one of 57 small molecule programs targeting Pulpitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
37 competitors in Contraception
Jadelle
Tivicay
Cytotec
Estrace
Implanon
Orgovyx
Jatenzo
Imdur
Ultram
Xylocaine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Apr 6, 1982
FELDENE
NDA NDA018147
Sources
Details